Business Description
Syngen Biotech Co Ltd
ISIN : TW0008279001
Description
Syngen Biotech Co Ltd is a biotechnology company. It is engaged in the manufacturing, sales, and trading of microbial pharmaceutical raw materials. It also provides the design and development of health food and biochemical nutrition. The company's products include pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.41 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 1.33 | |||||
| Interest Coverage | 33.16 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.35 | |||||
| Beneish M-Score | -2.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.9 | |||||
| 3-Year EBITDA Growth Rate | 8.9 | |||||
| 3-Year EPS without NRI Growth Rate | 7.8 | |||||
| 3-Year Book Growth Rate | 9.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.49 | |||||
| 9-Day RSI | 45.6 | |||||
| 14-Day RSI | 45.72 | |||||
| 6-1 Month Momentum % | -14.52 | |||||
| 12-1 Month Momentum % | -14.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.21 | |||||
| Quick Ratio | 1.58 | |||||
| Cash Ratio | 0.48 | |||||
| Days Inventory | 94.93 | |||||
| Days Sales Outstanding | 56.97 | |||||
| Days Payable | 24.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.76 | |||||
| Dividend Payout Ratio | 0.56 | |||||
| 3-Year Dividend Growth Rate | 18.6 | |||||
| Forward Dividend Yield % | 3.76 | |||||
| 5-Year Yield-on-Cost % | 15.18 | |||||
| Shareholder Yield % | 6.68 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 35.39 | |||||
| Operating Margin % | 15.5 | |||||
| Net Margin % | 11.94 | |||||
| FCF Margin % | 12.54 | |||||
| ROE % | 11.31 | |||||
| ROA % | 7.71 | |||||
| ROIC % | 10.04 | |||||
| ROC (Joel Greenblatt) % | 16.1 | |||||
| ROCE % | 12.49 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.89 | |||||
| Forward PE Ratio | 10.86 | |||||
| PE Ratio without NRI | 14.66 | |||||
| Shiller PE Ratio | 15.14 | |||||
| Price-to-Owner-Earnings | 25.28 | |||||
| PEG Ratio | 1.32 | |||||
| PS Ratio | 1.78 | |||||
| PB Ratio | 1.64 | |||||
| Price-to-Tangible-Book | 1.65 | |||||
| Price-to-Free-Cash-Flow | 14.14 | |||||
| Price-to-Operating-Cash-Flow | 10.39 | |||||
| EV-to-EBIT | 12.58 | |||||
| EV-to-EBITDA | 9.29 | |||||
| EV-to-Revenue | 1.94 | |||||
| EV-to-FCF | 15.46 | |||||
| Price-to-Projected-FCF | 1.25 | |||||
| Price-to-DCF (Earnings Based) | 0.47 | |||||
| Price-to-DCF (FCF Based) | 1.23 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.09 | |||||
| Price-to-Graham-Number | 1.04 | |||||
| Price-to-Net-Current-Asset-Value | 15.8 | |||||
| Earnings Yield (Greenblatt) % | 7.94 | |||||
| FCF Yield % | 7.01 | |||||
| Forward Rate of Return (Yacktman) % | 9.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Syngen Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 2,000.409 | ||
| EPS (TTM) (NT$) | 8.8 | ||
| Beta | 0.15 | ||
| Volatility % | 18.87 | ||
| 14-Day RSI | 45.72 | ||
| 14-Day ATR (NT$) | 2.366327 | ||
| 20-Day SMA (NT$) | 133.25 | ||
| 12-1 Month Momentum % | -14.52 | ||
| 52-Week Range (NT$) | 127 - 177 | ||
| Shares Outstanding (Mil) | 27.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Syngen Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Syngen Biotech Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Syngen Biotech Co Ltd Frequently Asked Questions
What is Syngen Biotech Co Ltd(ROCO:8279)'s stock price today?
The current price of ROCO:8279 is NT$131.00. The 52 week high of ROCO:8279 is NT$177.00 and 52 week low is NT$127.00.
When is next earnings date of Syngen Biotech Co Ltd(ROCO:8279)?
The next earnings date of Syngen Biotech Co Ltd(ROCO:8279) is .
Does Syngen Biotech Co Ltd(ROCO:8279) pay dividends? If so, how much?
The Dividend Yield %  of Syngen Biotech Co Ltd(ROCO:8279) is 3.76% (As of Today), Highest Dividend Payout Ratio of Syngen Biotech Co Ltd(ROCO:8279) was 0.56. The lowest was 0.11. And the median was 0.32. The  Forward Dividend Yield % of Syngen Biotech Co Ltd(ROCO:8279) is 3.76%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers